SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-014155
Filing Date
2023-03-01
Accepted
2023-03-01 16:47:45
Documents
1
Period of Report
2023-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4066
  Complete submission text file 0001209191-23-014155.txt   5705
Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032
Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARKER THERAPEUTICS, INC. 3200 SOUTHWEST FREEWAY, SUITE 2240 HOUSTON TX 77027
Business Address
Agopyan Nadia (Reporting) CIK: 0001784758 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37939 | Film No.: 23694417